739359-10-5

Basic information

• Product Name: (1-METHYL-1H-INDAZOL-3-YL)METHYLAMINE
• Synonyms: (1-METHYL-1H-INDAZOL-3-YL)METHYLAMINE;3-(Aminomethyl)-1-methyl-1H-indazole;(1-Methyl-1H-indazol-3-yl)methylamine 97%;3-(Aminomethyl)-1-methyl-1H-indazole 97%;(1-Methyl-1H-indazol-3-yl)methanamine
• CAS NO: 739359-10-5
• Molecular Formula: C9H11N3
• Molecular Weight: 161.2
• Mol File: 739359-10-5.mol
• Article Data: 0

Chemical Properties

• Melting Point: 55 °C
• Boiling Point: 312.451 °C at 760 mmHg
• Flash Point: 142.766 °C
• Appearance: /
• Density: 1.224 g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.643
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 8.18±0.29(Predicted)
• CAS DataBase Reference: (1-METHYL-1H-INDAZOL-3-YL)METHYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: (1-METHYL-1H-INDAZOL-3-YL)METHYLAMINE(739359-10-5)
• EPA Substance Registry System: (1-METHYL-1H-INDAZOL-3-YL)METHYLAMINE(739359-10-5)

Safety Data

• Hazard Codes: C
• Hazardous Substances Data: 739359-10-5(Hazardous Substances Data)

Usage

Description

(1-METHYL-1H-INDAZOL-3-YL)METHYLAMINE is an organic compound with the chemical structure of a methylated indazole ring connected to a primary amine group. It is known for its potential use in the development of pharmaceuticals and as a small-molecule probe in scientific research.
Used in Pharmaceutical Research:
(1-METHYL-1H-INDAZOL-3-YL)METHYLAMINE is used as a small-molecule probe for studying the induced conformation in HIV TAR RNA, which is capable of binding drug-like fragments. This application is significant in the development of targeted therapies against HIV and other diseases where RNA conformation plays a crucial role in the disease process.
Used in Biochemical Studies:
In the field of biochemistry, (1-METHYL-1H-INDAZOL-3-YL)METHYLAMINE serves as a valuable tool for investigating the interactions between small molecules and RNA structures. Its use in studying the conformation changes induced in HIV TAR RNA upon binding can provide insights into the mechanisms of RNA-drug interactions and contribute to the design of more effective drugs.

InChI:InChI=1/C9H11N3/c1-12-9-5-3-2-4-7(9)8(6-10)11-12/h2-5H,6,10H2,1H3